AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06649201 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Vaginal Microbiome Evaluation
Description: A vaginal microbiome evaluation will be performed via vaginal exam by a gynecologist with collection of vaginal samples once pre-transplant, six months, and twelve months post-transplant.
Study NCT06386146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB-30355
Description: Oral administration
Study NCT04446585 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Automated External Defibrillator (AED)
Description: Deployment of AEDs
Study NCT04446585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training in cardiopulmonary resuscitation and AED use
Description: Residents will undergo 30-minute courses at study start and if needed during the trial period. During the course they will also be recruited as citizen responders
Study NCT04446585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Activation of citizen responders
Description: Citizen responders will be activated in case of suspected cardiac arrest through the heart runner app.
Study NCT06092398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PRP and PRFG in treatment of anal fistula
Description: The tract fistula was cleaned with betadine 10% before PRP and PRFP were applied. Then, 2 ml of PRP was injected around the fistula into the tissue (the penetration depth in injection was 5-6 mm), and 4 ml PRFP was mixed with 1 m thrombin and interpositioned into the tract. 2 ml of PRP was injected around the fistula into the tissue (the penetration depth in injection was 5-6 mm), and 4 ml PRFP was mixed with 1 m thrombin and interpositioned into the tract. The operation time was about 20-30 minutes, the clot formation usually takes about 8 minutes, but the anesthesia was extended to 20 minutes to make sure a complete clot in the place of fistula
Study NCT05004467 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobilization With Movement Technique
Description: The researcher explains cervical movements to the patient to be done while the technique is performed. This movements will be the painful and limited movements detected in goniometric intervention before the treatment and movements done actively and in all range of motion.
Study NCT05004467 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Mobilization With Movement Technique
Description: The researcher explains cervical movements to the patient to be done while the technique is performed. This movements will be the painful and limited movements detected in goniometric intervention before the treatment and movements done actively and in all range of motion.
Study NCT05325112 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FFRCT
Description: FFRCT is a diagnostic test following a CCTA to help diagnose and treat coronary artery disease.
Study NCT05452902 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EXCAP Exercise
Description: 12 weeks of at-home walking and resistance exercise.
Study NCT05452902 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition Education
Description: 12 weeks of implementing eating tips and tracking food.
Study NCT05189106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Each participant will be treated with open-label baricitinib for 24 weeks. Participants will receive 2 mg baricitinib by mouth daily for the first 8 weeks and 4 mg baricitinib by mouth daily for the remaining 16 weeks.
Study NCT05724784 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Flourish
Description: Flourish is a text messaging program that aims to improve coping following cyberbullying and reduce suicide risk among youth.
Study NCT05822375 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Better Together Physician Coaching
Description: Better Together Physician Coaching Program thought-based coaching. This type of coaching focuses on thoughts and beliefs. It combines a cognitive behavioral therapy (CBT) model with mindfulness-based awareness and integrates theories of acceptance and commitment therapy (ACT), nonattachment, and radical questioning from Socratic and Greek philosophies. BT delivers a robust coaching experience via a 4-month web-based, group-coaching model. This novel program allows residents to participate as actively as they are inclined and able, offering flexibility via multiple modalities of coaching: twice weekly group coaching calls, unlimited anonymous written coaching, and weekly self-study modules that are housed on a secure members-only website.
Study NCT04732325 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Description: Researchers will program the spinal cord stimulation (SCS) system to deliver, according to the randomization status of the participant, burst, kHz, tonic, and sham stimulation.
Study NCT06532344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-7913
Description: Specified dose on specified days
Study NCT06532344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4538
Description: Specified dose on specified days
Study NCT06532344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Specified dose on specified days
Study NCT06532344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofolinate
Description: Specified dose on specified days
Study NCT06532344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Specified dose on specified days
Study NCT06532344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: Specified dose on specified days
Study NCT04777955 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stabilization exercises
Description: Core is at the center of almost all kinetic chains in the body. Core force, balance, and motion control maximize all kinetic chains of upper and lower limb function. A stable and strong core can contribute to more efficient use of the lower extremities. Core stability is defined as the ability of the lumbo-pelvic hip complex to prevent bending of the vertebral column and return to balance after perturbation.~Neuromuscular electrical stimulation (NMES) is a technique in which muscle contraction is electrically stimulated in the area where the surface electrodes are connected. It improves secondary muscle atrophy and weakness in immobilization by preventing a decrease in muscle protein synthesis.~Kinesiological banding (CT) is a treatment method used in the treatment of various musculoskeletal and neuromuscular deficits. The mechanism of action of CT is to facilitate muscle activation, increase blood and lymph circulation and reduce pain due to neurological suppression.
Study NCT04862039 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) devices
Description: Virtual Reality (VR) devices. Subjects receiving the experimental treatment will be given a VR headset, headphones and wristband and the Philips wireless fetal-maternal monitoring system, after the necessary preparation of the abdominal skin.
Study NCT05543135 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: basic audiological evaluation
Description: pure tone audiometry\&immitancemetry
Study NCT04797663 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nd-YAG laser
Description: laser hair removal device
Study NCT05535010 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transforaminal epidural steroid injection(TFESI)
Description: TFESI procedure will be applied again in the 3rd week and 3rd month for the patients whose NRS score decreased by less than 50 percent after the first procedure.
Study NCT05535010 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transforaminal epidural steroid injection(TFESI)
Description: TFESI procedure will be applied again in the 3rd week and 3rd month for the patients whose NRS score decreased by less than 50 percent after the first procedure.
Study NCT04797663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TCA 20%
Description: chemical peel
Study NCT05847972 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: MWM (Mobilization with movement)
Description: This manipulation is intended to improve ankle dorsiflexion. One session of 3 sets of 20 slow ankle dorsiflexion's separated by 10 seconds of rest will be performed.
Study NCT05847972 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MWM (Mobilization with movement)
Description: This manipulation is intended to improve ankle dorsiflexion. One session of 3 sets of 20 slow ankle dorsiflexion's separated by 10 seconds of rest will be performed.
Study NCT05847972 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Plantar orthoses
Description: Procedure: MWM All participants will undergo MWM. This manipulation is intended to improve ankle dorsiflexion. One session of 3 sets of 20 slow ankle dorsiflexion's separated by 10 seconds of rest will be performed.~Procedure: Plantar orthoses The moulds will be taken immediately after the manipulation. The PO will be made of resin (0.8mm +1.2mm), 2mm hard EVA heel stabiliser, 3mm semi-hard EVA cover. The PO should be worn for 3 months to obtain the results of the study.
Study NCT04629326 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 68Ga-WL12 PET/CT
Description: WL12, labeled with PET radio-nuclide ( Ga-68 )will be used as a molecular imaging tracer for PET/CT scanning
Study NCT05476588 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Screening
Description: Screening and validation of assessment tool translated into Spanish
Study NCT05442034 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: growth factors to help in regeneration
Description: regenerative therapy
Study NCT05442034 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: growth factors to help in regeneration
Description: regenerative therapy
Study NCT05130957 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage Application with clove oil
Description: The experimental group is given a massage with clove oil,
Study NCT05130957 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Massage Application without any oil
Description: The control group is given a massage without any oil as a standard midwifery care.
Study NCT05818605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise Program
Description: Subjects randomized to the EXER arm will undergo 24 weeks of Moderate Intensity Exercise Training (MIET). Patients will be signed up for 60-minute exercise sessions, 3 times a week
Study NCT04809077 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Reverse total shoulder replacement
Description: Long-term radiographic and clinical data of patients who underwent a reverse shoulder replacement
Study NCT05847972 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Plantar orthoses
Description: Procedure: MWM All participants will undergo MWM. This manipulation is intended to improve ankle dorsiflexion. One session of 3 sets of 20 slow ankle dorsiflexion's separated by 10 seconds of rest will be performed.~Procedure: Plantar orthoses The moulds will be taken immediately after the manipulation. The PO will be made of resin (0.8mm +1.2mm), 2mm hard EVA heel stabiliser, 3mm semi-hard EVA cover. The PO should be worn for 3 months to obtain the results of the study.
Study NCT05153408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-701
Description: BLU-701 for oral administration
Study NCT05153408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: osimertinib
Description: Osimertinib tablets for oral administration
Study NCT05153408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: IV infusion of carboplatin
Study NCT05153408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pemetrexed
Description: IV infusion of pemetrexed
Study NCT06555094 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Ecological momentary assessment (EMA)
Description: 4x/day brief smartphone-based EMA surveys assessing negative emotions and STBs
Study NCT06555094 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Description: TAU (or usual care) during hospitalization and the 28-day post-discharge period
Study NCT06555094 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Treatment as usual (TAU)
Description: TAU (or usual care) during hospitalization and the 28-day post-discharge period
Study NCT06555094 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief skills sessions plus EMI skills practice prompts
Description: (1) Three brief treatment sessions delivering core cognitive behavioral therapy (CBT) skills (mindful emotion awareness, cognitive flexibility, and changing emotional behaviors) (during hospitalization), (2) a discretionary booster session to reinforce treatment session content (that may be offered after discharge via either phone or telehealth), and (3) ecological momentary intervention (EMI) prompts to engage in guided skills practice exercises via smartphone
Study NCT05227274 — intervention group
Intervention type: OTHER
Intervention: Items completion with or without a MFM-Play
Description: Patients will completed 3 MFM during the follow-up, two times using the MFM-Play, and one without the MFM-Play Delay between each MFM completion will be 1 month ± 15 days
Study NCT06178510 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: INTELLiVENT-ASV.
Description: INTELLiVENT-ASV® is a closed-loop ventilation mode that automatically adjusts respiratory rate and tidal volume according to the oxygen and ventilatory patient needs
Study NCT05058872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levonorgestrel/ethinyl estradiol
Description: Levonorgestrel 0.15mg/ethinyl estradiol 0.03mg
Study NCT05058872 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comparator
Study NCT05595473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RZ-001 Dose 1
Description: RZ-001 Dose 1 and VGCV
Study NCT05595473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RZ-001 Dose 2
Description: RZ-001 Dose 2 and VGCV
Study NCT05595473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RZ-001 Dose 3
Description: RZ-001 Dose 3 and VGCV
Study NCT05595473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RZ-001 Dose 4
Description: RZ-001 Dose 4 and VGCV
Study NCT06249126 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Primary Fusion (Open Reduction Internal Fixation (ORIF) + Primary Subtalar Arthrodesis (PSTA)
Description: Definitive fixation by joint fusion
Study NCT06249126 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Open Reduction Internal Fixation (ORIF) only
Description: Definitive fixation with plates and screws
Study NCT06372639 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trans-Cranial Magnetic Stimulation
Description: Brain stimulation by the TMS device will be given after a deliberate memory re-activation, using repetitive pulses at 1Hz frequency for 15 minutes, the target area will be determined based on an fMRI scan in the resting state of the subject.
Study NCT06372639 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Trans-Cranial Magnetic Stimulation
Description: Brain stimulation by the TMS device will be given after a deliberate memory re-activation, using repetitive pulses at 1Hz frequency for 15 minutes, the target area will be determined based on an fMRI scan in the resting state of the subject.
Study NCT05219344 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tissue flossing
Description: After the standardized warm-up, participants will be instructed to stand still with their legs shoulder-width apart. The floss band (1.3 mm thick, 50 mm wide, 2 meters long, and strength level 3), consisting of a thick elastic latex band (COMPRE Floss, Sanctband), will be applied bilaterally around the distal third of the thigh. The applied pressure will be individualized by thigh circumferences, whereas low target pressure was chosen for this study, showing potential to elicit the most beneficial outcomes following flossing. The pressure will be monitored by the PicoPress device, which was placed at the middle distance of the application of the floss band to ensure that the entire surface of the pressure sensors was always completely covered. The flossing will be applied for 2 minutes with 2 minutes rest between sets. During flossing application subjects will be instructed to conduct 10 deep squats followed by 15 repetitions of knee extensions without added weight.
Study NCT05219344 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tissue flossing
Description: After the standardized warm-up, participants will be instructed to stand still with their legs shoulder-width apart. The floss band (1.3 mm thick, 50 mm wide, 2 meters long, and strength level 3), consisting of a thick elastic latex band (COMPRE Floss, Sanctband), will be applied bilaterally around the distal third of the thigh. The applied pressure will be individualized by thigh circumferences, whereas low target pressure was chosen for this study, showing potential to elicit the most beneficial outcomes following flossing. The pressure will be monitored by the PicoPress device, which was placed at the middle distance of the application of the floss band to ensure that the entire surface of the pressure sensors was always completely covered. The flossing will be applied for 2 minutes with 2 minutes rest between sets. During flossing application subjects will be instructed to conduct 10 deep squats followed by 15 repetitions of knee extensions without added weight.
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2mg QY201 tablets or 2mg QY201 placebo,BID
Description: 2mg QY201 tablets or 2mg QY201 placebo,BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5mg QY201 tablets or 5mg QY201 placebo,BID
Description: 5mg QY201 tablets or 5mg QY201 placebo,BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10mg QY201 tablets or 10mg QY201 placebo,QD
Description: 10mg QY201 tablets or 10mg QY201 placebo,QD
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10mg QY201 tablets or 10mg QY201 placebo,BID
Description: 10mg QY201 tablets or 10mg QY201 placebo,BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 15mg QY201 tablets or 15mg QY201 placebo,BID
Description: 15mg QY201 tablets or 15mg QY201 placebo,BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg QY201 tablets or 20mg QY201 placebo,BID
Description: 20mg QY201 tablets or 20mg QY201 placebo,BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5mg QY201 tablets，BID
Description: 5mg QY201 tablets，BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10mg QY201 tablets，BID
Description: 10mg QY201 tablets，BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg QY201 tablets，BID
Description: 20mg QY201 tablets，BID
Study NCT05525715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QY201 placebo，BID
Description: QY201placebo，BID
Study NCT04760457 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implant placement with flapped surgery
Description: Four mini implants will be placed reflecting a flap.
Study NCT04760457 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implant placement with flapless surgery
Description: Four mini implants will be placed without reflecting a flap.
Study NCT04760457 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implant immediate loading
Description: Four mini implants will be immediately loaded.
Study NCT04760457 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implant delayed loading
Description: Four mini implants will be loaded after a 6-week healing period.
Study NCT06281002 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: conventional impression stone casts digitization
Description: Nine conventional physical open tray impressions will be poured into a hard dental stone to obtain nine definitive implant casts with conventional implant analogs to act as a reference comparator.~Impressions will be digitized to reference STL files.
Study NCT06281002 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital scanning with coupled scanning aiding device
Description: Nine optical impressions will be obtained while additional geometric scanning aids are coupled with the scan bodies to get nine CAD/CAM 3D-printed polymer casts with digital implant analogs.
Study NCT06281002 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital Implant Model assessment of accuracy
Description: The nine STL files of optical scanning will serve as reference data for comparison with the digitized DIMs to evaluate the accuracy of representation of the actual position of implants in the software.
Study NCT05257213 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin solution
Description: 3 ml saline solution containing 5000 IU heparin.
Study NCT05257213 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anti-adhesion barrier gel
Description: 2 ml biodegradable barrier gel containing sodium hyaluronate (10 mg/ml), sodium chloride (8.5 mg/ml), disodium hydrogen phosphate (0.34mg/ml), sodium dihydrogen phosphate (0.14 mg/ml) and water for injection (QS to weight).
Study NCT04846478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talazoparib
Description: capsule, taken by mouth, once a day
Study NCT06493838 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: intravenous 50 mL of saline injection of 0.9% after umbilical cord clamping.
Description: intravenous 50 mL of saline injection of 0.9% after umbilical cord clamping.